Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Receivables - Other of $5.1 million for Q4 2025, up 6.91% year-on-year from $4.8 million in Q4 2024, and up 6.91% on a QoQ basis from $4.8 million in Q4 2024.
Curaleaf Holdings (CURLF) Receivables - Other (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Receivables - Other for 7 consecutive years, with $5.1 million the latest figure, recorded in Q4 2025.
- Quarterly Receivables - Other rose 6.91% year-over-year to $5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 million (up 6.91% YoY) and the FY2025 annual result came in at $5.1 million, up 6.91% from the prior year.
- Receivables - Other grew to $5.1 million in Q4 2025 per CURLF's latest filing, from $4.8 million in the prior quarter.
- Over the last five years, Receivables - Other for CURLF reached as high as $5.8 million in Q4 2021 and fell as low as -$33.8 million in Q1 2021.
- A 5-year average of -$1.8 million and a median of $4.8 million in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2021 — Receivables - Other soared 136.62% — and 2023, when it tumbled 50.42%.
- Year by year, Receivables - Other stood at $5.8 million in 2021, then retreated by 17.13% to $4.8 million in 2022, then slumped by 50.42% to $2.4 million in 2023, then jumped by 100.21% to $4.8 million in 2024, then increased by 6.91% to $5.1 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $5.1 million, $4.8 million, and $2.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.09 Mn |
| Dec 31, 2025 | 5.09 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Dec 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Mar 31, 2021 | -33.75 Mn |
| Mar 31, 2021 | -33.75 Mn |
| Dec 31, 2020 | 2.45 Mn |
| Dec 31, 2020 | 2.45 Mn |
| Sep 30, 2020 | -37.06 Mn |
| Sep 30, 2020 | -37.06 Mn |
| Dec 31, 2019 | 996,000.00 |
| Dec 31, 2019 | 996,000.00 |